AlamarBio is a groundbreaking brand that is redefining the limits of Protein Biomarker Detection. With unrivaled precision, sensitivity, and simplicity, they offer a range of innovative products and services to transform the field of proteomics. Their NULISA Platform utilizes attomolar sensitivity to detect and quantify low-abundance targets, enabling the discovery and validation of critical new protein biomarkers.

With a dynamic range of 10 logs, NULISA supports the quantification of a broad range of biological expression levels without dilution. Its flexible, multiplex chemistry allows researchers to focus on a single target or multiplex hundreds to thousands of targets in a single experiment. AlamarBio also offers the ARGO System, a fully automated, high-throughput precision proteomics platform.

With integrated on-board computing and data analysis, it streamlines the process from sample to data or to pooled NGS library. The ARGO System enables rapid results in as little as 6 hours for single-plex assays and 15 hours for multiplex NGS assays, accelerating biomarker development. With their groundbreaking technologies, AlamarBio is revolutionizing our understanding of the human proteome and its role in health and disease